Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1750-1326
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency ; volume:12 ; number:1 ; day:5 ; month:5 ; year:2017 ; pages:1-18 ; date:12.2017
Molecular neurodegeneration ; 12, Heft 1 (5.5.2017), 1-18, 12.2017

Schlagwort
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit

Urheber
Agadjanyan, Michael G.
Beteiligte Personen und Organisationen
Zagorski, Karen
Petrushina, Irina
Davtyan, Hayk
Kazarian, Konstantin
Antonenko, Maxim
Davis, Joy
Bon, Charles
Blurton-Jones, Mathew
Cribbs, David H.
Ghochikyan, Anahit
SpringerLink (Online service)

DOI
10.1186/s13024-017-0172-1
URN
urn:nbn:de:1111-201705113589
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:36 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Agadjanyan, Michael G.
  • Zagorski, Karen
  • Petrushina, Irina
  • Davtyan, Hayk
  • Kazarian, Konstantin
  • Antonenko, Maxim
  • Davis, Joy
  • Bon, Charles
  • Blurton-Jones, Mathew
  • Cribbs, David H.
  • Ghochikyan, Anahit
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Novel humanized monoclonal antibodies against ROR1 for cancer therapy

Novel humanized monoclonal antibodies against ROR1 for cancer therapy

Tyrosine O-sulfation proteoforms affect HIV-1 monoclonal antibody potency

Tyrosine O-sulfation proteoforms affect HIV-1 monoclonal antibody potency

Molecular basis for dengue virus broad cross-neutralization by humanized monoclonal antibody 513

Molecular basis for dengue virus broad cross-neutralization by humanized monoclonal antibody 513

IC100, a humanized therapeutic monoclonal anti-ASC antibody alleviates oxygen-induced retinopathy in mice

IC100, a humanized therapeutic monoclonal anti-ASC antibody alleviates oxygen-induced retinopathy in mice

Development of a humanized anti-FABP4 monoclonal antibody for potential treatment of breast cancer

Development of a humanized anti-FABP4 monoclonal antibody for potential treatment of breast cancer

A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies

A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies

Humanized mice

Aufsatzsammlung

Humanized mice

Humanized mice

Aufsatzsammlung | Online-Publikation

Humanized mice

PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritis

PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritis

2D4, a humanized monoclonal antibody targeting CD132, is a promising treatment for systemic lupus erythematosus

2D4, a humanized monoclonal antibody targeting CD132, is a promising treatment for systemic lupus erythematosus

Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice

Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice

Intravenous administration of anti-vascular endothelial growth factor humanized monoclonal antibody bevacizumab improves articular cartilage repair

Intravenous administration of anti-vascular endothelial growth factor humanized monoclonal antibody bevacizumab improves articular cartilage repair

Verbundene Objekte